Related Experiment Video
Updated: Jun 17, 2025

04:05
Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
Published on: October 6, 2023
365
Thyrotoxic Periodic Paralysis: A Case Report with Patient Perspective.
Aliaksandra Baranskaya1, Yimeng Zhang2, Brian Lee3
1Acute Medical Unit, City Hospital, Sandwell and West Birmingham NHS Trust, Birmingham, UK, Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Acute Medicine
|August 12, 2024
Summary
Thyrotoxic Periodic Paralysis (TPP) can cause sudden, life-threatening limb weakness. Early diagnosis and treatment are crucial for rapid recovery, especially in diverse populations.
Area of Science:
- Endocrinology
- Neurology
Background:
- Thyrotoxic Periodic Paralysis (TPP) is a rare condition causing acute muscle weakness.
- It is more prevalent in certain ethnic groups, particularly males of Asian descent.
Observation:
- A case report detailing a patient's first-person account of TPP onset and progression.
- The patient experienced insidious onset and rapid deterioration of limb weakness.
Findings:
- Spot diagnosis of TPP was achieved through pattern recognition.
- Prompt thyroid function testing and treatment led to quick resolution of the medical emergency.
Implications:
- Highlights the importance of considering TPP in differential diagnoses for acute limb weakness.
- Emphasizes the need for increased awareness of TPP in culturally diverse medical settings.
- Underscores the critical role of timely intervention in managing this potentially fatal condition.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
723
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
723
Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29

